Lyrica looking grim: Pfizer blockbuster's market share crumbles under generic attack

19th August 2019 Uncategorised 0

Pfizer knew things would take a turn for the worse after generics for its blockbuster Lyrica launched stateside three short weeks ago. But did the company know it would lose this much—and so fast?

More: Lyrica looking grim: Pfizer blockbuster's market share crumbles under generic attack
Source: fierce